Compare DuPont de Nemours Inc (DD) vs Procter & Gamble Co (PG) Price & Performance

DuPont (DD) trades at $132.48, up 1.07% today, showing strong recent earnings beats but facing profitability challenges with a net margin of 0.79%. Technical indicators are neutral, with the stock trading near key resistance at $132. Recent news highlights innovation in sustainable materials and legal settlements over PFAS claims. The company's cash flow has been negative in recent years, though 2026 projections show improvement.

The outlook is mixed: analyst consensus is bullish (58.5% buy ratings) with a high price target of $172, but the current price exceeds the consensus target of $95. Key risks include ongoing legal liabilities, volatile earnings, and high debt. Revenue growth and margin expansion in healthcare and water technologies present opportunities, but investors should weigh these against significant financial and legal headwinds.

Procter & Gamble (PG) trades at $150.59, up 1.87% with bullish technical momentum as it approaches resistance near $151. The company demonstrates strong fundamentals with consistent earnings beats, 18.44% net margins, and robust cash flow generation. Recent partnership with the WNBA highlights strategic brand expansion while maintaining a 69-year dividend growth streak. Valuation metrics show premium multiples relative to peers, with P/E at 22.75 and P/S at 4.19.

PG offers stable growth with dividend reliability but faces valuation concerns amid modest revenue expansion. The consensus price target of $160.13 suggests 6.3% upside potential, supported by 53 analyst ratings favoring Buy (52.8%). Key risks include premium valuation pressure and competitive market dynamics. The stock presents a defensive investment opportunity with consistent cash flow generation in consumer staples.